DanCann Pharma A/S publishes Q4-2021 report
COPENHAGEN, Denmark, 25 February 2022 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) hereby today releases its results for the period 1 October – 31 December 2021 (the “period”). The Q4-2021 report is available as an attached document to this press release and at www.dancann.com.Group key figures Q4 2021 KDKK 01/10/21 01/10/20 31/12/20 01/01/21 31/12/21 01/01/20 31/12/20 31/12/21Net sales 874 0 874 0Operating -4,718 -2,721 -14,509 -5,871